): The primary goal of the Research Oncology Training Program is to prepare Predoctoral and Postdoctoral participants for investigative careers in cancer research. The Predoctoral Training Program provides a forum within the Biomedical Sciences Training Program (BSTP) at Case Western Reserve University (CWRU) School of Medicine for graduate training that emphasizes cancer research. Trainees will conduct their thesis research under the guidance of Cancer Center faculty in the Ph.D. degree-granting programs of Molecular Biology, Biochemistry, Cell Biology, Neuroscience, Genetics, Pathology, Pharmacology and Physiology and Biophysics. Predoctoral Trainees will participate in the Core Academic Program of the BSTP during the first year of training and then, during subsequent years of training, participate in d i d actic course work focused specifically on cancer research. The Postdoctoral Training Program integrates the training of physician scientists (M.D. or M.D./Ph.D.) and basic scientists (Ph.D.) under the direction of select Cancer Center faculty who bridge traditional departmental boundaries to apply multidisciplinary approaches to fundamental problems in oncology. Physician trainees without previous research training will attend graduate level basic science courses as needed to bring their level of knowledge up to that of a Ph.D. or M.D./Ph.D. trainee. Pre- and Postdoctoral Trainees will be unified as an interactive group through participation in a monthly dinner meeting which they help to organize, a weekly Cancer Genetics and Cancer Biology Journal Club, a weekly Cancer Center Seminar, and a special session at the annual Cancer Center retreat that features trainee presentations. Formal training will also include an annual Radiation Safety course and an annual course on ethics. The Training Program will be governed by a Steering Committee charged with responsibility for (i) active recruitment of trainees, with an emphasis on women and underrepresented minorities; (ii) selection of high caliber candidates who are fully committed to research careers; (iii) tracking the progress of trainees according to specified criteria and standards; (iv) evaluating the mentorship provided by individual faculty; and (v) tracking the success of trainees who have completed the training program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA059366-08
Application #
6172497
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1993-06-01
Project End
2003-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
8
Fiscal Year
2000
Total Cost
$197,944
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Barker, Emily C; Kim, Byung-Gyu; Yoon, Ji Hee et al. (2018) Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation. Carcinogenesis 39:36-46
Reinartz, Roman; Wang, Shanshan; Kebir, Sied et al. (2017) Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma. Clin Cancer Res 23:562-574
Samaeekia, Ravand; Adorno-Cruz, Valery; Bockhorn, Jessica et al. (2017) miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway. Clin Cancer Res 23:1091-1103
Sahni, Jennifer M; Gayle, Sylvia S; Webb, Bryan M et al. (2017) Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors. Cancer Res 77:5395-5408
Seachrist, Darcie D; Sizemore, Steven T; Johnson, Emhonta et al. (2017) Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Breast Cancer Res 19:66
Zhao, Yiqing; Scott, Anthony; Zhang, Peng et al. (2017) Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis. Oncotarget 8:48782-48793
Bryson, Benjamin L; Junk, Damian J; Cipriano, Rocky et al. (2017) STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle 16:319-334
Gayle, Sylvia S; Sahni, Jennifer M; Keri, Ruth A (2017) BETi induction of mitotic catastrophe: towing the LIN9. Oncoscience 4:128-130
Junk, D J; Bryson, B L; Smigiel, J M et al. (2017) Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene 36:4001-4013
Bartel, Courtney A; Parameswaran, Neetha; Cipriano, Rocky et al. (2016) FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance. Oncotarget 7:52597-52612

Showing the most recent 10 out of 82 publications